"The eClinical Forum is unique in the way that information is shared amongst companies", stated Ken Light, Executive Vice President of Operations for OmniComm Systems. "Ultimately, the entire industry benefits from the open exchange. We are pleased to have been long-standing members and participants in this progressive organization".
"We are all looking forward to this November's workshop being hosted in Fort Lauderdale," said Suzanne Bishop, US Facilitator of eClinical Forum. "OmniComm has been a strong contributor in the eClinical Forum, and an active participant on our steering committee. We are very pleased that they have chosen to host our Autumn workshop near their Fort Lauderdale headquarters."
The autumn meeting will include facilitated sessions on current issues with investigator portals, adverse event reporting, source data verification and eSource, and integration with Electronic Health Records.
About eClinical Forum
The Forum (www.eClinicalForum.org) was founded in 2000 with the idea to discuss all areas of eClinical and Electronic Data capture. There are more than 50 companies that are members of the eClinical Forum, a transatlantic association. They include companies from both Pharmaceutical and related industries. There goal is to provide "practical information, approach and learning experiences required to maximize the success of the eClinical initiatives." Funding is solely based on the contributions from their members, which allows them to unbiasedly discuss any interest of their members. The advantage of becoming part of eClinical Forum is its panoptic collection of information solely available to its members.
About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's pricing model is easily understood and allows companies ranging from small, to large, to maximize their clinical research investments. OmniComm Systems, Inc has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.
Safe Harbor Disclaimer
Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
CONTACT: | |
Ken Light | |
OmniComm Systems, Inc. | |
732-960-2830 | |
Klight@OmniComm.com | |
SOURCE OmniComm Systems, Inc.
